Halozyme Therapeutics shares owned by Samalin Investment Counsel
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Samalin Investment Counsel
from 13F filings
Historical chart of Samalin Investment Counsel investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Samalin Investment Counsel consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Samalin Investment Counsel
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $685k | 11k | 63.82 |
| 2024-12-31 | $507k | 11k | 47.81 |
| 2024-09-30 | $558k | 9.7k | 57.24 |
| 2024-06-30 | $626k | 12k | 52.36 |
| 2024-03-31 | $508k | 13k | 40.68 |
| 2023-09-30 | $411k | 11k | 38.20 |
| 2023-06-30 | $239k | 6.6k | 36.07 |
More positions owned by Samalin Investment Counsel
View all positions for Samalin Investment Counsel